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Chronic necrotizing pulmonary aspergillosis (CNPA) is a rare form of pulmonary aspergillosis. The
radiological ﬁndings in CNPA are very diverse. We present a mildly imunosuppresive, elderly 71-year-old
woman with the diagnosis of chronic necrotizing pulmonary aspergillosis presenting as transient
migratory thoracic mass.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Case report
A 71-year-old woman was admitted to our hospital, with a
complain of productive cough accompanying yellow coloured
viscous sputum. She had a past history of type II diabetes controlled
with oral antidiabetics. Eventhough she had never smoked, a his-
tory of biomass exposure was found. On admission, her body
temperature was 36.7 C; respiratory rate was 12/min; blood
pressure was 110/70 mm/Hg and heart rate was 85 beats/min. On
physical examination, no lymphadenopathy was found and dry
crackles were audible over both lung bases. The haematocrit was
42.8% and the white cell count was 14800 cells/mm3 with 91%
neutrophils, 5.5% lymphocytes and no eosinophils. Patient had
three sputum smears with ARB negative. Pulmonary function test
showed restrictive pattern. CT scan of the chest demonstrated
collapse of the left lower lobe and mucus bronchograms in the
central bronchi (Fig. 1a). Flexible bronchoscopy has been applied
revealed the presence of mucoid and abundant secretion in both
bronchial tree and no endobronchial lesion had been seen. The
mucosal biopsies which were taken from left lower lobe consisted
with inﬂamed bronchial mucosa. Bronchial washing was negative
for ARB and consistent with inﬂammation. An oral antibiotic ther-
apy was given empirically. Three weeks later, however, symptoms
did not improve and a second chest CT showed radiological
disappearance of inﬁltration and collapse on the left lung (Fig. 1b)
and new focal ground-glass opacities involving base of the right
upper and right middle lobe were seen (Fig. 2). The patient wasChest Surgery Training and
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Ltd. This is an open access article uadministered seftiriakson (2  1 gr/day) (i.v.). Because of migratory
pulmonary inﬁltrates, serum collagen tissue markers were studied
with the suspicion of criptogenic organising pneumonia (COP).
Serum levels of collagen markers were at normal range, and
bronchoscopy was repeated. Histopathological examination of the
transbronchial lung biopsy specimens were demonstrated
desquamated airway epithelial cells, accumulations of anthracotic
pigment and ﬁbrous connective tissue. Corticosteroid treatment
was started with a strong clinical suspicion of COP and the patient
was taken into follow up. Chest radiograph revealed a cavitary
lesion in the right upper lobe at the ﬁrst month of steroid treat-
ment. CT scan of chest revealed cavitary lessions on the right upper
lobe with cavitation of collapse consolidation areas on the middle
lobe and right lower lobe. On the left lower lobe from the new
collapse consolidation area were also seen (Fig. 3a-3b-3c). Serum
galactomannan was negative. Then a transthoracic thin needle bi-
opsy (TTNB) was applied to the cavitary lesion. Histopathological
examination of the biopsy showed congested lung parenchyma,
lymphocyte inﬁltration in the bronchial walls and numerous ﬁla-
mentous fungal hyphae that is morphologically consistent with
Aspergillus (Fig. 4). As there was a strong clinical suspicion about
COP because of migratuar inﬁltration we decided to perform TTNB
from the area of collapse and consolidation on the right lower lobe.
But the pathological examination was not consisted with organis-
ing pneumonia. With the diagnosis of CNPA, the patient received a
2-week treatment with amphotericin B (1  50 mg) and showed
excellent clinical improvement. After one month of amphotericin B
therapy at control CT even the lesions on the right and left lower
lobe showed on improvement, the cavitary lesions on the right
upper lobewere stable. During the follow-up, therewere no clinical
and radiological progression but she admitted again with the samender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. a: Collapse of the left lower lobe. b: Disappearance of inﬁltration in left lung.
Fig. 2. New focal ground-glass opacities right upper lobe.
Fig. 3. a-b-c: Cavitary lessions and new collapse consolidation area on the left lower lobe.
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consolidation on the left lower lobe (Fig. 5) and ﬂexible bron-
choscopy was performed to the patient again. Bronchial mucosal
biopsy and bronchial washing were taken from the left lower lobe.
Bronchial washing culture showed aspergillus and candida. The
patient received a 2-week treatment with amphotericin-B(1  50 mg). At the end of the second week of treatment,
amphotericin-B was changed to oral voriconazole 200 mg twice a
day. As there was clinical and radiological improvement was ach-
ieved, antifungal therapy was discontinued at the end of the 6th
month.
2. Discussion
Pulmonary aspergillosis can present in different clinical, path-
ological and radiological forms depending on the patient's immu-
nological status and underlying pulmonary disease. Allergic
bronchopulmonary aspergillosis, aspergilloma, invasive and semi-
invasive forms can be recognized. CNPA also called semi-invasive
or subacute invasive aspergillosis, is an indolent, cavitary infec-
tious process in the lung parenchymasecondary to local invasion by
Aspergillus spp., usually Aspergillus fumigatus, with a slowly pro-
gressive clinical course [1]. It is an uncommon manifestation ofaspergillosis and usually affects in middle aged and elderly in-
dividuals with altered local defenses, associated with underlying
chronic lung diseases such as chronic obstructive pulmonary dis-
ease (COPD), previous pulmonary tuberculosis, thoracic surgery,
radiation therapy, pneumoconiosis, cystic ﬁbrosis, lung infarction
or sarcoidosis [2]. It may also occur in patients who are mildly
Fig. 4. Aspergillus hyphae.
Fig. 5. Collapse and consolidation on the left lower lobe after 1.5 year.
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prolonged low-dose corticosteroid therapy, malnutrition, or con-
nective tissue diseases such as rheumatoid arthritis and ankylosing
spondylitis [3]. The risk factors of our patient were old age and
diabetes mellitus. Clinical manifestations of which depends on the
virulence of the fungus, intensity of exposure, patient's immuno-
logical status. Patients presents with constitutional symptoms such
as fever, malaise, fatigue and weight loss of 1e6 months duration,
in addition to chronic productive cough and hemoptysis which
varies from mild to severe [4].The radiological ﬁndings in CNPA were very diverse. In those
with CNPA, there is local invasion of the lung tissue and a pre-
existing cavity is not needed. Usually a single area of consolida-
tion is found in an upper lobe which progresses over days or weeks
with cavitation. Pleural thickening and fungus balls may occur as
well as pneumothorax and pleural effusion [5]. In our case CT scan
of the chest demonstrated collapse of the left lower lobe andmucus
bronchograms in the central bronchi which disappeared three
weeks after on the second CT. New focal ground-glass opacities
involving base of the right upperlobe and right middle lobe with a
pleural effusion were seen on the right side. Even the absence of a
histopathological conﬁrmation this migrating opacities made us to
think organising pneumonia on the clinical and radiological bases
and the patient was given a corticosteroid treatment. On the third
week of corticosteroid treatment chest radiograph revealed a
cavitary lessionwhichwas thought that the ground glass opacity on
the second CT was being cavitated. As the patients lession progress
under corticosteroid theraphy, histological conﬁrmation was
needed and we decided to perform TTNB from the cavitary lession
which revealed the diagnosis of CNPA. There was another lession of
collaps and consolidation on the right lower lobe mimicking the
ﬁrst lession on the ﬁrst CT which was on the left lower lobe. So in
order to exclude the diagnosis of organising pneumonia which will
need a different approach a second TTNB from the lession on the
right lower lobe was relavent with anthracotic lung parenchyma,
congestion and not consistent with organising pneumonia. Patient
was given antifungal theraphy and on follow up all the lessions
regressed on contol CT with a clinical improvement. On these
radiological ﬁndings to our knowledge this is the ﬁrst case having
migratuar opacities due to CNPA. Tas¸cı at al presented a case of
BOOP mimicking a malignant disorder and occurring after asper-
gillus infection in a patient with chronic obstructive pulmonary
disease but they did not report any migratuar lession [6].
CNPA should be considered in differentials when investigating a
case even if the patient does not have typical radiological ﬁndings.References
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